Загрузка...

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

Objectives To determine the respective efficacy of quetiapine and rivastigmine for agitation in people with dementia in institutional care and to evaluate these treatments with respect to change in cognitive performance. Design Randomised double blind (clinician, patient, outcomes assessor) placebo...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ballard, Clive, Margallo-Lana, Marisa, Juszczak, Edmund, Douglas, Simon, Swann, Alan, Thomas, Alan, O'Brien, John, Everratt, Anna, Sadler, Stuart, Maddison, Clare, Lee, Lesley, Bannister, Carol, Elvish, Ruth, Jacoby, Robin
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group Ltd. 2005
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC556156/
https://ncbi.nlm.nih.gov/pubmed/15722369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.38369.459988.8F
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!